Multiplikator Forward P/S: Vivos Therapeutics, Inc. (VVOS)
Vivos Therapeutics (VVOS) is implementing eco-friendly plastics and remote diagnostics, confirming the issuer's projected P/S ratio within the GURU.Markets chronology, where 0.20 determines the current value of the metric. Fundamentals are bolstered by high margins driven by a unique sleep apnea treatment platform, while an R&D breakthrough in non-invasive jaw correction devices promises a radical replacement for CPAP machines.
Ringkesan rincian data analitis Vivos Therapeutics Inc (VVOS)
- rega pasar lan target rega analis:
- indikator kapitalisasi bursa perusahaan:
- statistik nilai buku emiten:
- data utang lan likuiditas:
Total Utang marang Modal Vivos Therapeutics|VVOS - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Vivos Therapeutics|VVOS - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Vivos Therapeutics Inc|VVOS - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Vivos Therapeutics|Rasio cepet vivoslife.com
- rincian asil keuangan lan kelipatan valuasi:
VVOS - Penghasilan resik perusahaan|Bathi sing dikarepake Vivos Therapeutics|VVOS - Rasio kapitalisasi marang bathi resik|Prakiraan rega marang bathi Vivos Therapeutics, Inc|VVOS - Pangali PEG|Pangali EV/EBITDA Vivos Therapeutics Inc|VVOS - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Vivos Therapeutics|VVOS - Bathi saben siji saham sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan vivoslife.com|VVOS - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Vivos Therapeutics
- indikator dodolan lan pendapatan:
Analisis fundamental perusahaan:VVOS (Vivos Therapeutics, Inc.)
Institutional capital assesses the investment attractiveness of Vivos Therapeutics (VVOS) through the lens of the ratio between current market value and projected sales. The expected P/S metric calculates this coefficient in real-time, allowing for a comparison of the market price against the efficiency of the commercial rollout of devices under Kirk Huntsman's leadership, which confirms the asset's fundamental stability without overpaying for future growth.
Karo sapa Vivos Therapeutics saingan
Rasio rega marang prakiraan pendapatan Boston Scientific Corporation BSX|EW - Multiplikator forward rega marang pendapatan|ResMed Corp - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Insulet Inc.|ZBH: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan COO|ALGN (Align Technology) - Multiplikator Forward P/S|Globus Medical Inc (GMED) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S TMDX|Multiplikator forward rega marang pendapatan Alphatec Corp ATEC|Multiplikator Forward P/S AORT (Artivion, Inc.)|Multiplikator Forward P/S enovis.com ENOV|IART - Rasio rega marang prakiraan pendapatan|ESTA: Rasio rega marang prakiraan pendapatan|BBNX (Beta Bionics Corp) - Multiplikator forward rega marang pendapatan|IRADIMED Inc. - Rega forward marang dodolan|EMBC (Embecta Corp.) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep tandemdiabetes.com TNDM|Rasio rega marang prakiraan pendapatan Axogen (AXGN)|SI-BONE Inc (SIBN) - Prakiraan rega marang pendapatan|Orthofix International - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S Bioventus Global BVS|OrthoPediatrics Inc. - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake treace.com TMCI|Strata Critical Medical (SRTA) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan CARL (Carlsmed, Inc.)|Rasio rega marang prakiraan pendapatan RxSight Corp|Multiplikator forward rega marang pendapatan ClearPoint (CLPT)|Multiplikator Forward P/S STXS|STIM - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan Sight Sciences SGHT|OBIO: Kapitalisasi marang prakiraan pendapatan|ANIK: Multiplikator forward rega marang pendapatan|InspireMD Inc. - Rasio rega marang pendapatan sing dikarepake|ZJYL (zhjmedical.com) - Multiplikator forward rega marang pendapatan|VANI (Vivani Medical) - Rasio rega marang prakiraan pendapatan|XTNT (Xtant Medical Holdings, Inc.) - Multiplikator Forward P/S|NeuroOne (NMTC) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator forward rega marang pendapatan MODD (Modular Medical)|Rasio rega marang prakiraan pendapatan MYO (Myomo Inc)|Rasio rega marang prakiraan pendapatan Envoy Medical, Inc. COCH|envveno.com (NVNO) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|SINT - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake Tenon Medical Inc. TNON|LFWD (ReWalk Robotics Ltd) - Multiplikator forward rega marang pendapatan|Autonomix Medical - Rega forward marang dodolan|Multiplikator forward rega marang pendapatan IVF|BBLG (bonebiologics.com) - Rasio rega marang pendapatan sing dikarepake|Multiplikator Forward P/S AXNX|BIOL (BIOLASE Inc.) - Rega forward marang dodolan|Multiplikator Forward P/S DYNT (Dynatronics)|Paragon 28 Inc. (FNA) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|INVO - Rasio rega marang prakiraan pendapatan
